[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address 54.145.176.252. Please contact the publisher to request reinstatement.
[Skip to Content Landing]
Article
November 1978

Esophagogastric Variceal HemorrhageIts Treatment by Percutaneous Transhepatic Coronary Vein Occlusion

Author Affiliations

From the Departments of Surgery (Drs Johnson and Nabseth) and Radiology (Drs Widrich and Robbins), Tufts University School of Medicine at the Boston Veterans Administration Hospital.

Arch Surg. 1978;113(11):1331-1338. doi:10.1001/archsurg.1978.01370230121015
Abstract

• The angiographic technique of percutaneous transhepatic coronary vein occlusion was used to treat esophagogastric variceal bleeding in 38 patients. There were two categories of patients: those actively bleeding who had not been controlled by continuous vasopressin infusion and/or Blakemore tube tamponade, and those with portal hypertension who were not actively bleeding at the time of transhepatic portal venography but who were at high risk for recurrent variceal hemorrhage. Coronary vein occlusion was achieved in 33 patients by (1) metal clip and cotton devices (one); (2) balloon catheter occlusion (two); (3) heat-treated autogenous clot and powdered absorbable gelatin sponge (Gelfoam) (13); and (4) Gelfoam strips soaked in sodium tetradecyl sulfate (17). Percutaneous coronary vein occlusion was effective in controlling 81% of the patients with actively bleeding varices. In patients who were not actively bleeding, percutaneous transhepatic coronary vein occlusion seemed to afford good protection for recurrent variceal hemorrhage.

(Arch Surg 113:1331-1338, 1978)

×